The US Food and Drug Administration (FDA) has approved the belimumab 200 mg/mL autoinjector for children aged 5 years of older with active lupus nephritis (LN) who are receiving standard therapy.

New research by Swansea University and the University of Cambridge has revealed the causes and devastating impacts of delays ...

NeuroScientific Biopharmaceuticals has ventured into stem cell therapy with a $5.1M purchase of unlisted Perth-based company ...

Question: My teenage daughter has a sore on the side of her lip. She is prone to cold sores but she says this feels entirely ...

One of the leading causes of kidney disease in non-diabetics is high blood pressure, also called hypertension. The kidneys ...

The mother-of-two has a unique form of systemic sclerosis, called scleroderma. This condition can cause symptoms such as ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

Medically reviewed by Stella Bard, MD Lupus is a chronic autoimmune disease in which your immune system mistakenly attacks ...

New research by Swansea University and Cambridge University has revealed the causes and devastating impacts of delays—that ...